相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Optimising piperacillin/tazobactam dosing in paediatrics
Christoffer W. Tornoe et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Pharmacometrics at FDA: Evolution and impact on decisions
J. R. Powell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Impact of pharmacometric reviews on new drug approval and labeling decisions - a survey of 31 new drug applications submitted between 2005 and 2006
V. A. Bhattaram et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients
Brian P. Booth et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The management of heparin-induced thrombocytopenia
D Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications
VA Bhattaram et al.
AAPS JOURNAL (2005)
Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes
L Risch et al.
INTENSIVE CARE MEDICINE (2004)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects
SK Swan et al.
PHARMACOTHERAPY (2000)
The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
SK Swan et al.
PHARMACOTHERAPY (2000)
分享论文
